ES2178076T3 - Activador de celulas t citotoxicas y su empleo. - Google Patents
Activador de celulas t citotoxicas y su empleo.Info
- Publication number
- ES2178076T3 ES2178076T3 ES98109072T ES98109072T ES2178076T3 ES 2178076 T3 ES2178076 T3 ES 2178076T3 ES 98109072 T ES98109072 T ES 98109072T ES 98109072 T ES98109072 T ES 98109072T ES 2178076 T3 ES2178076 T3 ES 2178076T3
- Authority
- ES
- Spain
- Prior art keywords
- activator
- antigen
- protector
- ctl
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940126530 T cell activator Drugs 0.000 title abstract 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 title 1
- 239000012190 activator Substances 0.000 abstract 5
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 230000001012 protector Effects 0.000 abstract 4
- 239000012790 adhesive layer Substances 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 101710194807 Protective antigen Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- LCTXBFGHZLGBNU-UHFFFAOYSA-M amprolium Chemical compound [Cl-].NC1=NC(CCC)=NC=C1C[N+]1=CC=CC=C1C LCTXBFGHZLGBNU-UHFFFAOYSA-M 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229940115893 corid Drugs 0.000 abstract 1
- 210000002615 epidermis Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Adhesive Tapes (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
ACTIVADOR CTL, PROTECTOR Y ESPECIFICO DEL ANTIGENO, PREFERENTEMENTE EN FORMA DE EMPLASTO, QUE COMPRENDE EL ANTIGENO PROTECTOR Y UN ESCIPIENTE FARMACEUTICAMENTE ACEPTABLE, UTILIZANDOSE EL ACTIVADOR PARA APLICACION EXTERIOR A UNA SUPERFICIE DE CELULAS DE LANGERHANS EPIDERMICAS, ACTIVADAS POR ALTERACION MECANICA O QUIMICA DE UN ESTRATO CORNEO DE LA EPIDERMIS, EN PARTICULAR UN ACTIVADOR EN EL QUE DICHO EMPLASTO COMPRENDE UN SOPORTE Y UNA CAPA ADHESIVA QUE INCLUYE EL ANTIGENO PROTECTOR DE MANERA LIBERABLE, ENCONTRANDOSE LA CITADA CAPA ADHESIVA LAMINADA SOBRE UN LADO DEL SOPORTE, UN PROCEDIMIENTO PARA ACTIVAR LA CELULA T ASESINA ESPECIFICA DEL ANTIGENO EN UN MAMIFERO, CON EL USO DE DICHO ACTIVADOR Y EL USO DEL CITADO ANTIGENO PROTECTOR PARA LA PRODUCCION DE UN ACTIVADOR DE CELULAS T PROTECTOR Y ESPECIFICO DEL ANTIGENO EN UN MAMIFERO. DADO QUE EL ACTIVADOR DE LAS CTL ESPECIFICO DEL ANTIGENO DE LA INVENCION AMPLIA Y ACTIVA LAS CTL, CON LO QUE SE ERRADICA ESPECIFICAMENTE SOLO LAS CELULAS QUE TIENENUN ANTIGENO PROTECTOR, ES SUMAMENTE UTIL PARA LA PROFILAXIS Y EL TRATAMIENTO DEL CANCER INTRATABLE Y DE ENFERMEDADES PROVOCADAS POR INFECCION VIRAL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13003197A JP3879785B2 (ja) | 1997-05-20 | 1997-05-20 | キラーｔ細胞賦活剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2178076T3 true ES2178076T3 (es) | 2002-12-16 |
Family
ID=15024445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98109072T Expired - Lifetime ES2178076T3 (es) | 1997-05-20 | 1998-05-19 | Activador de celulas t citotoxicas y su empleo. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0891770B1 (es) |
| JP (1) | JP3879785B2 (es) |
| AT (1) | ATE222755T1 (es) |
| CA (1) | CA2238661C (es) |
| DE (1) | DE69807402T2 (es) |
| ES (1) | ES2178076T3 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
| AU4188100A (en) * | 1999-04-08 | 2000-11-14 | Gregory M. Glenn | Dry formulation for transcutaneous immunization |
| DK1372708T3 (da) | 2001-02-13 | 2008-10-20 | Us Gov Sec Army | Vaccine til transkutan immunisering mod rejsediarre |
| EP1963558B1 (en) * | 2005-11-04 | 2012-08-15 | Mannius zu dem Berge, Johan Patrick Olof Ermes | Method for preparing a textile material |
| US20100136092A1 (en) | 2007-03-01 | 2010-06-03 | Shinsaku Nakagawa | Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| AU2008246579A1 (en) | 2007-05-08 | 2008-11-13 | National University Corporation, Hamamatsu University School Of Medicine | Cytotoxic T cell activator comprising EP4 agonist |
| JPWO2009133863A1 (ja) | 2008-04-28 | 2011-09-01 | 国立大学法人浜松医科大学 | Ｅｐ１アゴニストを含有してなる免疫増強剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57156414A (en) * | 1981-03-23 | 1982-09-27 | Sekisui Chem Co Ltd | Adhesive tape or sheet for treatment |
| JP3189337B2 (ja) * | 1991-11-08 | 2001-07-16 | 日本電気株式会社 | 皮膚角層の除去器具および除去方法 |
| DE19525607A1 (de) * | 1995-07-14 | 1997-01-16 | Boehringer Ingelheim Kg | Transcorneales Arzneimittelfreigabesystem |
-
1997
- 1997-05-20 JP JP13003197A patent/JP3879785B2/ja not_active Expired - Fee Related
-
1998
- 1998-05-19 CA CA002238661A patent/CA2238661C/en not_active Expired - Fee Related
- 1998-05-19 DE DE69807402T patent/DE69807402T2/de not_active Expired - Lifetime
- 1998-05-19 ES ES98109072T patent/ES2178076T3/es not_active Expired - Lifetime
- 1998-05-19 AT AT98109072T patent/ATE222755T1/de not_active IP Right Cessation
- 1998-05-19 EP EP98109072A patent/EP0891770B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3879785B2 (ja) | 2007-02-14 |
| EP0891770B1 (en) | 2002-08-28 |
| DE69807402T2 (de) | 2003-04-17 |
| ATE222755T1 (de) | 2002-09-15 |
| EP0891770A1 (en) | 1999-01-20 |
| CA2238661C (en) | 2008-07-22 |
| CA2238661A1 (en) | 1998-11-20 |
| JPH10316585A (ja) | 1998-12-02 |
| DE69807402D1 (de) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2152979T3 (es) | Sistema terapeutico transdermal que contiene estradiol. | |
| ES2178076T3 (es) | Activador de celulas t citotoxicas y su empleo. | |
| BR0100026A (pt) | Artigo absorvente decomponìvel em água | |
| PE12297A1 (es) | Articulo absorbente que tiene propiedades mejoradas | |
| UY27943A1 (es) | Composiciones y mctodos para tratar el crncer usando inmunoconjugados de anticuerpo para cd44 citotnxicos y agentes quimioterapcuticos | |
| AR032912A1 (es) | Formulacion farmaceutica | |
| AR011577A1 (es) | Composicion para la administracion transdermica de una droga esteroide y formulacion transdermica que la incluye | |
| AR012614A1 (es) | Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento | |
| AR065378A1 (es) | Articulo absorbente con locion que comprende un material de polipropilenglicol | |
| DK241090D0 (da) | Lamineret komposit til transdermal administration af fentanyl | |
| DE69031217D1 (de) | Druckempfindliches adhäsionslaminat | |
| BR112018015938A2 (pt) | ?artigo absorvente? | |
| ES2122161T3 (es) | Adhesivo compuesto para adherir materiales que tienen diferentes propiedades de expansion. | |
| PE59696A1 (es) | Un articulo absorbente tal como un panal, un protector de incontinencia, una compresa sanitaria o un articulo similar | |
| AR056297A1 (es) | Articulo de proteccion higienica fijable al cuerpo que incluye un auxiliar de colocacion tactil | |
| AR057844A1 (es) | Toalla sanitaria que incluye un adhesivo que se orienta hacia el cuerpo | |
| CU20210003A7 (es) | Una preparación farmacéutica liposomal de mitoxantrona útil en el tratamiento de linfoma no de hodgkin | |
| ECSP056030A (es) | Sistema terapéutico transdérmico estable a los rayos uv | |
| ES2045377T3 (es) | Preparacion percutanea de tulobuterol. | |
| NO20074184L (no) | Anordning for a feste et ror til huden til en person | |
| ES2065647T3 (es) | Empleo cosmetico de una composicion que tiene una actividad antieritematosa. | |
| BR112018016123A2 (pt) | artigo absorvente | |
| EA200501828A1 (ru) | Тканепротекторные цитокины с увеличенным терапевтическим окном для защиты, восстановления и стимулирования реагирующих клеток, тканей и органов | |
| BR0314716A (pt) | Anticorpos de subunidade alfa de lfa-1 e métodos de uso | |
| ES2120281T3 (es) | Componente estratificado con elasticidad diferente en las zonas de borde. |